Fidessa has added Prospector, a liquidity tool that helps high-touch traders discover trading and crossing opportunities, to its Optimised Trading initiative. Products already offered as part of the initiative include Fidessa’s Order Performance Monitor, which allows users to monitor live orders simultaneously and identify outliers in real time, and OTAS Market Analytics, which provides insights into live trading conditions.
Prospector along with the other elements of Optimised Trading is tightly integrated with Fidessa’s order management system (OMS), avoiding the need for traders to switch between applications or rekey data in the search for liquidity. It monitors live and historical client trading activity, client watch lists, shareholdings data and traders’ interests.
It also allows traders to populate internal merchandise boards manually or automatically, and includes heat maps for live orders and historic activity to help traders quickly spot relevant matches, and an algorithm that dynamically reflects historical activity over time and delivers customised results to sales traders and their clients.
Jay Biancamano, head of equities product marketing for Fidessa in the Americas, says that as electronic trading has evolved with significant investment in innovation, there has been little innovation in high-touch trading, a shortfall the company aims to fill with its Optimised Trading initiative.
Talking about Prospector, he explains: “The search for liquidity is all about bringing together the right information, the right way, and then acting fast. Prospector delivers meaningful value for the buy-side and, importantly, is something buy-side firms will pay for.”
Prospector has been developed over the past year and is expected to find favour with over 100 Fidessa clients that are users of the company’s OMS. Further additions to the Optimised Trading initiative are in the pipeline and are likely to include new data sources, perhaps customer relationship management data, and more workflow solutions that are tightly integrated with the OMS.
Subscribe to our newsletter
